Shaw M T
Am J Hematol. 1977;2(3):237-43. doi: 10.1002/ajh.2830020305.
Conflicting evidence has been published as to the prognostic significance of the periodic acid-Schiff (PAS) reaction and cell size in acute lymphocytic leukemia (ALL). Therefore, a large collaborative study was undertaken to evaluate the prognostic significance of the PAS reaction and cell size of bone marrow lymphoblasts obtained at the time of diagnosis in children with ALL. Known prognostic factors (age and white blood cell [WBC] counts) were also evaluated. Data from 80 newly diagnosed cases of ALL were analyzed. These patients were treated with similar therapy by members of the Pediatric Division of the Southwest Oncology Group. The PAS reaction was scored. Microlymphoblasts were defined as having a diameter of less than or equal to 12 micron; macrolymphoblasts, greater than 12 micron. Patients 10 years and older at the time of diagnosis had a significantly shorter duration of first remission and survival than those younger than 10 years. Those with pretreatment peripheral WBCs of less than or equal to 25,000/microliter had significantly longer duration of first remission and survival than those with a peripheral WBC greater than 25,000/microliter. There was no significant difference in duration of first remission or survival in patients having predominantly macrolymphoblastic or microlymphoblastic marrows. PAS reaction was of no value in predicting the duration of first remission or survival.
关于过碘酸-希夫(PAS)反应及细胞大小在急性淋巴细胞白血病(ALL)中的预后意义,已有相互矛盾的证据发表。因此,开展了一项大型合作研究,以评估ALL患儿诊断时获得的骨髓原始淋巴细胞的PAS反应及细胞大小的预后意义。已知的预后因素(年龄和白细胞[WBC]计数)也进行了评估。对80例新诊断的ALL病例数据进行了分析。这些患者由西南肿瘤学组儿科部门的成员采用相似的疗法进行治疗。对PAS反应进行了评分。微小原始淋巴细胞定义为直径小于或等于12微米;大原始淋巴细胞定义为直径大于12微米。诊断时年龄在10岁及以上的患者首次缓解期和生存期明显短于10岁以下的患者。预处理时外周血白细胞小于或等于25,000/微升的患者首次缓解期和生存期明显长于外周血白细胞大于25,000/微升的患者。以大原始淋巴细胞为主或微小原始淋巴细胞为主的骨髓患者,其首次缓解期或生存期无显著差异。PAS反应在预测首次缓解期或生存期方面无价值。